Acetyl-CoA Detection and Quantification

High-Sensitivity Acetyl-CoA Detection and Quantification for Metabolic Research, Clinical Diagnostics, and Drug Development

Acetyl-coenzyme A (acetyl-CoA) is a central metabolite that links carbohydrate, fatty acid, and amino acid metabolism, serving as a critical substrate for the tricarboxylic acid (TCA) cycle, fatty acid synthesis, sterol biosynthesis, and protein acetylation. Its intracellular concentration and compartmental distribution are tightly regulated and reflect the metabolic state of cells, tissues, and organisms. Dysregulation of acetyl-CoA metabolism is implicated in a wide range of conditions, including cancer, diabetes, cardiovascular disease, and neurodegenerative disorders. Consequently, accurate and sensitive detection of acetyl-CoA is essential for basic metabolic research, biomarker discovery, and the evaluation of drugs targeting metabolic pathways. Our specialised detection platform offers a fully validated suite of analytical methods—including ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS), isotope-dilution mass spectrometry, and enzyme-coupled fluorometric assays—delivering unparalleled sensitivity, specificity, and reproducibility across diverse biological matrices. Whether the client is a pharmaceutical company, a clinical research organisation, or an academic laboratory, our service provides the precise, regulatory‑ready data required to advance metabolic studies and therapeutic development.

Scientific and Clinical Rationale for Acetyl-CoA Analysis

Clients seeking acetyl-CoA detection services are motivated by a range of critical objectives. In metabolic research, the primary need is to quantify acetyl-CoA levels in various cellular compartments (cytosol, mitochondria, nucleus) to understand metabolic flux, substrate availability, and the regulation of acetylation reactions. In drug discovery and development, evaluating the effect of candidate compounds on acetyl-CoA production or utilisation is essential for assessing their mechanism of action and potential off-target effects. In clinical diagnostics and biomarker studies, measuring acetyl-CoA in blood, plasma, or tissue biopsies can provide insights into metabolic disorders and serve as a prognostic or pharmacodynamic marker. In nutritional and dietary research, monitoring acetyl-CoA responses to feeding, fasting, or supplementation is fundamental to understanding energy homeostasis. In quality control for biopharmaceuticals, acetyl-CoA is sometimes used as a cofactor in enzymatic reactions; its purity and concentration must be verified. Our service is architected to address these diverse requirements with a flexible, ISO 17025‑accredited analytical framework that adapts to the specific matrix (cell lysates, tissues, plasma, fermentation broths) and the client's research or regulatory context.

Integrated Analytical Pipeline for High‑Fidelity Acetyl-CoA Profiling

Our analytical platform is organised into three interconnected modules that collectively ensure reliable and reproducible acetyl-CoA quantitation. The Sample Preparation Module employs optimised extraction and stabilisation protocols tailored to the matrix—including acidic precipitation for cell cultures, mechanical homogenisation with perchloric acid for tissues, and protein precipitation with acetonitrile for plasma. To prevent degradation of the labile thioester bond, all procedures are performed at low temperature with rapid processing and the addition of stabilising agents. We incorporate an isotopically labelled internal standard (e.g., ¹³C₃‑acetyl-CoA) at the earliest step to correct for extraction losses and matrix effects, achieving recoveries of 92–98% with relative standard deviations (RSD) < 3%. The Chromatographic and Detection Module uses ultra‑high‑performance liquid chromatography (UHPLC) with a C18 reversed‑phase column (1.7 µm) and a gradient mobile phase of aqueous ammonium acetate and acetonitrile, achieving baseline separation of acetyl-CoA from other acyl‑CoA species (e.g., succinyl‑CoA, malonyl‑CoA, propionyl‑CoA) within a run time of 8 minutes. Detection is performed by tandem mass spectrometry (MS/MS) in positive electrospray ionisation (ESI) mode with multiple reaction monitoring (MRM) transitions (m/z 810→303 and 810→262), providing LOQs as low as 0.5 nM in cell extracts and 1 nM in plasma, with inter‑day precision < 4% RSD and accuracy of 95–105%. For absolute quantification, we use isotope dilution with matrix‑matched calibration to eliminate ion suppression effects. The Data Validation Module includes system suitability tests (retention time, peak symmetry, signal‑to‑noise ratio), quality control samples at low, medium, and high concentrations, and regular participation in inter‑laboratory proficiency testing to ensure ongoing accuracy. All methods are validated according to ICH Q2(R1) and FDA Bioanalytical Method Validation guidelines, and we provide full validation dossiers including specificity, linearity, accuracy, precision, LOD, LOQ, recovery, matrix effect, and stability.

Unmatched Sensitivity, Selectivity, and Metabolic Coverage

Our platform routinely delivers performance that surpasses regulatory and typical research requirements. The UHPLC‑MS/MS method provides a dynamic linear range spanning four orders of magnitude (0.5 nM to 10 µM), enabling the quantitation of both basal and stimulated acetyl-CoA levels in a single run. The MRM transitions are highly specific, with no detectable interference from isobaric compounds or endogenous matrix components. For more challenging matrices (e.g., heavily lipid‑rich tissues or plasma with high protein content), we employ solid‑phase extraction (SPE) using a mixed‑mode sorbent to further clean up the sample, achieving signal‑to‑noise ratios > 500:1 at the LOQ. In addition to acetyl‑CoA, we can simultaneously quantify up to 15 other acyl‑CoA species in a single injection, providing a comprehensive snapshot of the cellular acyl‑CoA pool. We also offer subcellular fractionation followed by acetyl‑CoA measurement to distinguish mitochondrial from cytosolic pools, which is critical for studying metabolic compartmentation. Our automated sample handling and high‑throughput capability allow processing of up to 384 samples per day, making our service ideal for large‑scale screening or time‑course studies. This depth and breadth of analysis ensure that our clients receive not only a concentration value but also a rich metabolic context for their research.

Distinctive Advantages of Our Acetyl-CoA Detection Service

Our service offers several unique benefits that directly address client challenges. First, we provide customised method selection and development—clients can choose between our standard high‑throughput MS/MS assay, an ultra‑sensitive method for scarce samples (e.g., biopsy specimens), or a cost‑effective enzyme‑linked fluorometric assay for semi‑quantitative screening. Second, we maintain a comprehensive in‑house library of certified reference materials and stable isotope‑labelled internal standards for acetyl‑CoA and its related acyl‑CoA species, ensuring accurate quantification and reducing the burden on clients to source these reagents. Third, we offer a rapid turnaround service for urgent clinical or pharmacokinetic samples, with results available within 24 hours of sample receipt. Fourth, our stability studies evaluate the degradation of acetyl‑CoA under various storage and handling conditions, providing evidence‑based recommendations for sample collection and preservation. Fifth, we provide comprehensive data interpretation and statistical analysis, including comparison with control groups, fold‑change calculations, and multivariate visualisation (PCA, heatmaps) to help clients extract meaningful biological insights. Sixth, all our methods are accredited under ISO/IEC 17025 and comply with GLP guidelines, and we participate in international proficiency testing schemes (e.g., EQAS, FAPAS) to continuously verify our accuracy. Our team of metabolomics specialists and analytical chemists provides consultative support, assisting clients in experimental design, data interpretation, and troubleshooting.

Advanced Data Integration, Predictive Modeling, and Reporting

We understand that analytical data must inform scientific decision‑making. Our final reports are structured to deliver three levels of information: (i) a certificate of analysis (CoA) presenting the acetyl‑CoA concentration (with measurement uncertainty) and a clear comparison to the client's specified reference range or acceptance criteria; (ii) a detailed analytical report containing raw chromatograms, calibration curves, quality control data, sample preparation details, and instrument parameters; and (iii) an interpretive summary that places the results in the context of the client's research objectives—for example, explaining how a significant change in acetyl‑CoA levels may indicate a shift in metabolic flux, or how the ratio of acetyl‑CoA to CoA‑SH (free coenzyme A) reflects cellular energy status. For clients with multiple time‑points or treatment groups, we perform statistical analysis (t‑tests, ANOVA) and provide trend plots to visualise changes over time. We also offer predictive modeling of metabolic pathway activity based on acetyl‑CoA and related metabolites, using our internally developed algorithms. All raw data files (e.g., .raw, .csv, .dx) are supplied for full transparency and re‑analysis.

Broad Applications Across Drug Discovery, Clinical Research, and Nutrition

The versatility of our acetyl‑CoA detection service makes it invaluable across multiple sectors. In drug discovery and pharmacology, our assays support target validation, mechanistic studies, and the evaluation of metabolic modulators. In clinical research and diagnostics, we quantify acetyl‑CoA in patient‑derived samples (plasma, urine, tissue biopsies) to explore its role as a biomarker for diseases such as diabetes, non‑alcoholic fatty liver disease, and cancer. In nutrition and dietary intervention, our measurements inform studies on ketogenic diets, fasting, and exercise metabolism. In cell biology and biochemistry, we provide the precise data needed to study acetylation, epigenetics, and mitochondrial function. In industrial biotechnology, we monitor acetyl‑CoA in fermentation processes to optimise the production of biofuels and biochemicals. Our ability to adapt the analytical approach to the specific matrix, scale, and regulatory environment ensures that we serve a diverse clientele with efficiency and expertise.

Commitment to Innovation, Quality, and Client Partnership

We are dedicated to maintaining leadership in acyl‑CoA analytics through continuous technological advancement and a culture of scientific excellence. Our current R&D includes the development of microfluidic chip‑based devices for near‑real‑time acetyl‑CoA monitoring in live cell cultures, and the integration of machine learning algorithms to predict metabolic flux from multi‑analyte data. We actively participate in standardisation working groups (e.g., Metabolomics Standards Initiative, CASMI) and contribute to the development of reference materials and best practices. Our quality management system is ISO 17025 and ISO 9001 certified, and we undergo regular external audits. We offer flexible service models—from single‑sample analysis to long‑term collaborative projects—with dedicated account management, volume‑based pricing, and priority handling for urgent requests. Our global logistics network provides sample kits with preservatives (e.g., trichloroacetic acid, EDTA) and clear instructions to ensure acetyl‑CoA stability during transport. Turnaround times are typically 3–5 business days for standard MS/MS analysis and 5–7 business days for comprehensive profiling, with expedited options available. We maintain open, transparent communication, providing preliminary results upon request and final reports with full documentation. Our success is measured by the confidence our clients have in their data, enabling them to make sound scientific and commercial decisions. We invite you to partner with us for precise, reliable, and insightful acetyl‑CoA detection services.

In summary, our acetyl‑CoA detection service delivers a comprehensive, precise, and regulation‑ready analytical solution that combines state‑of‑the‑art UHPLC‑MS/MS, rigorous quality assurance, and expert interpretative support. By offering unmatched sensitivity, specificity, and adaptability across all relevant sample types, we empower our clients to advance metabolic research, accelerate drug development, and improve clinical diagnostics. We look forward to supporting your acetyl‑CoA analysis needs with our unwavering commitment to quality.